Scyx stock nasdaq
Stocks Outlook: SCYNEXIS (SCYX) – New Magazin Research SCYNEXIS (SCYX) stock price is trading at a gap of 10.77% away from the 20-Day SMA and figured out a distance of 14.80% from the its 50-Day SMA. SMA 50 is an average stock price from the last 50 days calculated as an unweighted mean of the previous 50 stock closing prices. NASDAQ:SCYX SCYNEXIS, Inc. Stock Analysis - CapitalCube Summary quote, performance, and fundamental analysis for NASDAQ:SCYX SCYNEXIS, Inc. SCYNEXIS (NasdaqGM:SCYX) - Share price, News & Analysis ... SCYNEXIS, Inc., a biotechnology company, delivers therapies for the treatment fungal infections in the United States. It is developing its lead product candidate, ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections.
SCYNEXIS (SCYX) stock price is trading at a gap of 10.77% away from the 20-Day SMA and figured out a distance of 14.80% from the its 50-Day SMA. SMA 50 is an average stock price from the last 50 days calculated as an unweighted mean of the previous 50 stock closing prices.
SCYNEXIS, Inc. is engaged in the discovery, development and commercialization of anti-infectives. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of several fungal infections, including serious invasive fungal infections. SCYNEXIS (SCYX) Stock Message Board - InvestorsHub Lead product is SCY-078 for the treatment of several serious fungal infections. Both oral and new IV formulations are now in Phase I with results expected in June and July 2016. Is It Right Time to Be Cautious on SCYNEXIS Inc. (NASDAQ ... Maxim Group advised investors in its research note published on June 27, 2018, to Buy the SCYX stock while also putting a $6 price target. The stock had earned Buy rating from Guggenheim Markets when it published its report on October 24, 2017. That day the Guggenheim set price target on the stock to $6.
SCYNEXIS, INC. : SCYX Stock Price | MarketScreener
SCYNEXIS - SCYX - Stock Price & News | The Motley Fool Apr 02, 2020 · Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, … SCYX: SCYNEXIS Inc - Stock Price, Quote and News - CNBC Get SCYNEXIS Inc (SCYX:NASDAQ) real-time stock quotes, news and financial information from CNBC.
SCYNEXIS: An Update On This ~$2 'Lottery Ticket ...
Technical Analysis of SCYNEXIS INC (NASDAQ:SCYX) — … A fast and easy way to analyze US Stocks Technical analysis gauges display real-time ratings for the selected timeframes. The summary for SCYNEXIS INC is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. SCYX | SCYNEXIS Inc. Stock Price & News - WSJ SCYNEXIS Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time SCYX stock price. SCYX - Scynexis Stock Price - Barchart.com SCYNEXIS, Inc. (NASDAQ : SCYX) today announced the closing of its previously announced underwritten public offering of 38,888,889 shares of common stock and … SCYNEXIS Inc (SCYX) Quote | Morningstar
Feb 07, 2020 · What does Kenneth Fisher think of SCYNEXIS, Inc. (SCYX)? Analyze SCYX using the investment criteria of Kenneth Fisher at NASDAQ.com
Maxim Group advised investors in its research note published on June 27, 2018, to Buy the SCYX stock while also putting a $6 price target. The stock had earned Buy rating from Guggenheim Markets when it published its report on October 24, 2017. That day the Guggenheim set price target on the stock to $6.
SCYX - Stock quote for SCYNEXIS, INC. - MSN Money View the latest SCYX stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of SCYNEXIS, INC.. msn back to msn home money. SCYNEXIS, Inc. (NASDAQ:SCYX) Rare Value And Growth Stock Opportunity: SCYNEXIS Inc ...